John Canan
Fortune : 4 M $ au 31/05/2026
Fortune : 4 M $ au 31/05/2026
John Canan worked for Merck & Co., Inc. as Senior VP-Finance & Global Controller from 2014 to 2014.
He also worked for Schering-Plough Corp.
as Chief Accounting Officer, SVP & Global Controller from 2009 to 2009, and for Merck Sharp & Dohme Corp.
as Senior Vice President & Controller from 2009 to 2009.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Terex Corp.
Terex Corp. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets aerial work platforms and materials processing machinery 0,06 % | 27/04/2026 | 64 456 ( 0,06 % ) | 4 M $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Comptroller/Controller/Auditor | 01/03/2014 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Comptroller/Controller/Auditor | 03/11/2009 |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Comptroller/Controller/Auditor | 01/11/2009 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national